Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Watson Pharm

Article Abstract:

The price appreciation potential of the shares of Watson Pharmaceuticals Inc. for the years 2010-2012 is discussed. The Corona, California-based company is involved in the development, manufacture, marketing, sale, and distribution of brand and generic pharmaceutical products.

Author: Gray, Jerry W., Jr.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2008
Pharmaceutical preparations, Securities issued, listed, United States, Stocks, Watson Pharmaceuticals Inc., WPI, Company securities, Analyst report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Teva Pharm

Article Abstract:

The price appreciation potential of the shares of Teva Pharmaceutical Industries Ltd. for the years 2010-2012 is discussed. The Israeli company offers generic and proprietary branded drugs, including Copaxone for multiple sclerosis, and active pharmaceutical ingredients.

Author: Ferrara, J. Susan
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Teva Pharmaceutical Industries Ltd.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Evaluation, Pharmaceutical industry, Securities, Stock prices
Similar abstracts:
  • Abstracts: King Pharm. Teva Pharm
  • Abstracts: Watson Pharm. OSI Pharma., Inc
  • Abstracts: Enzon Pharm., Inc. PDL BioPharma
  • Abstracts: inVentiv Health, Inc. A. Schulman Inc
  • Abstracts: inVentiv Health, Inc. Ansys, Inc. Block (H&R)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.